Home / Hydralazine / United States
US ATC C02DB02 · updated 2 Nov 2026
Hydralazine shortage in United States
Is there a Hydralazine shortage in United States?
Yes. As of 2 Nov 2026, 1 Hydralazine product is reported short in United States, the first since 7 Apr 2020. No return date has been given. Main reason: not stated.
Also short in Canada, Japan, New Zealand, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03) | Meitheal Pharmaceuticals, Inc. | 7 Apr 2020 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).